SCHEMBL10112680

SCHEMBL10112680

CCOC(=O)Nc1cnc(N2CCC3(CC2)CCN([C@H]2CC[C@@H](O)CC2)C3=O)c(C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
OPRK1 P41145 4/20 0.34
TSHR P16473 1/20 0.34
FSHR P23945 1/20 0.34
P2RY12 Q9H244 5/20 0.33
DHODH Q02127 2/20 0.33
HPGD P15428 1/20 0.33
LMNA P02545 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
CASP3 P42574 1/20 0.33
RAB9A P51151 1/20 0.33
SENP8 Q96LD8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10112691 0.94 SMN1; SMN2 (0.36) ALDH1A1OPRK1TSHRFSHRP2RY12
SCHEMBL17082137 0.92 ALDH1A1 (0.36) ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL17082191 0.92 ALDH1A1 (0.36) ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4570147 0.92 ALDH1A1 (0.36) ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4570219 0.92 ALDH1A1 (0.36) ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL10112674 0.92 OPRK1 (0.36) ALDH1A1OPRK1DHODHOGA
SCHEMBL10112699 0.91 ROCK2 (0.35) ALDH1A1OPRK1TSHRFSHRDHODH
SCHEMBL10112711 0.91 P2RY12 (0.42) P2RY12
SCHEMBL4722689 0.89 DHODH (0.38) OPRK1DHODHCRBNOGA
SCHEMBL5629463 0.89 DHODH (0.38) OPRK1DHODHCRBNOGA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8193207-B2 Lactam compounds and methods of using the same INCYTE CORPORATION (US) 2012-06-05 US disclosed
US-8193207-B2 Lactam compounds and methods of using the same INCYTE CORPORATION (US) 2012-06-05 US disclosed
WO-2007067504-A2 LACTAM COMPOUNDS AND METHODS OF USING THE SAME INCYTE CORPORATION (US) 2007-06-14 WO disclosed
US-20070129345-A1 Lactam compounds and methods of using the same INCYTE CORPORATION 2007-06-07 US disclosed
US-20070129345-A1 Lactam compounds and methods of using the same INCYTE CORPORATION 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129345-A1 Lactam compounds and methods of using the same HSD11B1, HSD17B11, HSD17B1 ALDH1A1 94/4885GRIN2D 3245/4885GRIN3B 2632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.